May 2022 $45 M Issued in a merger or acquisition $10 to $50 million 0
Predictive Therapeutics Ltd.: Private sale, May 2022 × Investors in this round 0 investors had bought by the notice of May 24, 2022: 0 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $45 M of $45 M offered
Smallest investment taken no minimum stated
What was sold equity, options or other rights to buy securities, securities to be acquired by exercising them Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Bermuda People named in the notice Asher Nathan · Executive Officer, Director · CEO and Director Robert Harow · Executive Officer, Director · CFO, COO and Director J. Tomilson Hill · Director Paul Marinelli · Director Roger Kornberg · Director Seo-Yong Tomilson Cho · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the amounts: “Total offering amount represents the deemed value of Issuer's shares issued to InterX, Inc. shareholders in a merger, consisting of $4.7 million of common shares issued at closing, and $40 million of preferred shares to be issued post-closing.”Signed by Robert Harow, Director, CFO and COO. Source: SEC Form D, newest notice filed May 24, 2022. Read the notice at the SEC .
equity, options SEC Sep 2019 $38 M No. 3 $10 to $50 million 48
Predictive Therapeutics Ltd.: Raise no. 3, Sep 2019 × Investors in this round 48 investors had bought by the notice of Oct 23, 2019: 48 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $38 M of $45 M offered; $7 M still to sell
Smallest investment taken $13,900
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue No revenue
Sales commissions $902,857
Finders' fees $80,000
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Bermuda People named in the notice Robert Harow · Executive Officer, Director Asher Nathan · Director · Other than the payment of salaries and other compensation and benefits no officer, director, or promoter will receive an Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round Bradley Woods & Co. Ltd. (CRD 13660) · broker-dealer Eric Singer (CRD 718955) · New York, New York Sold in CA, CO, CT, DE, FL, GA, IL, MA, MD, NC, NJ, NY, PA, TX Remarks in the notice On fees: “In addition the finder received 42,993 warrants as consideration”On the use of proceeds: “Other than the payment of salaries and other compensation and benefits no officer, director, or promoter will receive any payments from the proceeds of this offering.”Signed by Robert Harow, Cfo. Source: SEC Form D, newest notice filed Oct 23, 2019. Read the notice at the SEC .
equity SEC Jun 2017 $9 M No. 2 $2 to $10 million 20
Predictive Therapeutics Ltd.: Raise no. 2, Jun 2017 × Investors in this round 20 investors had bought by the notice of Dec 18, 2018: 20 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $9 M (amount offered: indefinite)
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last more than a year
Issuer's revenue No revenue
Sales commissions none
Finders' fees $650,000
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
Estimates the notice marks finders' fees as estimates
The company Corporation, incorporated in Bermuda People named in the notice Robert Harow · Executive Officer, Director Asher Nathan · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round Bradley Woods & Co. Ltd. (CRD 13660) · broker-dealer Eric Singer (CRD 718955) · New York, New York Sold in CA, CT, MA, MD, NJ, NY Remarks in the notice On the use of proceeds: “Other than the payment of salaries and other compensation and benefits no officer, director, or promoter will receive any payments from the proceeds of this offering.”Signed by Robert Harow, Cfo. Source: SEC Form D, newest notice filed Dec 18, 2018. Read the notice at the SEC .
equity SEC Nov 2014 $9 M No. 1 $2 to $10 million 50
Predictive Therapeutics Ltd.: Raise no. 1, Nov 2014 × Investors in this round 50 investors had bought by the notice of Aug 21, 2019: 50 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $9 M of $18 M offered; $9 M still to sell
Smallest investment taken $17,000
What was sold equity, options or other rights to buy securities, securities to be acquired by exercising them Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last more than a year
Issuer's revenue No revenue
Sales commissions $630,000
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Bermuda People named in the notice Robert Harow · Executive Officer, Director Asher Nathan · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round First Liberties Securities (CRD 14432) · broker-dealer Eric Singer (CRD 718955) · New York, New York Sold in DE, FL, IL, MA, MD, NJ, NY, TX Bradley Woods & Co. Ltd. (CRD 13660) · broker-dealer Eric Singer (CRD 718955) · New York, New York Sold in FL, IL, MA, MD, NJ, NY, TX Remarks in the notice On the amounts: “The Total Amount Sold includes the amount was reported in the original filing ($2,493,856). The Remaining to be sold amount includes the exercise price for the shares underlying the warrants issued.”On the use of proceeds: “Other than the payment of salaries and other compensation and benefits no officer, director, or promoter will receive any payments from the proceeds of this offering.”Signed by Robert Harow, Cfo. Source: SEC Form D and 1 amendment, newest notice filed Aug 21, 2019. Read the notice at the SEC .
equity, options SEC